Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases

被引:17
|
作者
Kamata, M
Denda-Nagai, K
Kubota, N
Aida, S
Takeda, K
Irimura, T
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo, Japan
[2] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan
关键词
DNA vaccine; natural killer cells; tumor immunity;
D O I
10.1023/A:1021332932531
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
C57BL/6 mice were immunized intradermally with various doses of purified pCEP4 plasmid DNA containing full-length MUC1 cDNA (22 tandem repeats). Mice immunized with MUC1 DNA three times at weekly intervals had serum antibodies to a synthetic peptide corresponding to the tandem repeats of MUC1. The antibody titer correlated with the plasmid DNA dose. After the third immunization mice were injected intravenously with 5 x 10(5) B16-F10 melanoma cells that had been stably transfected with MUC1 cDNA (F10-MUC1-C8 clone cells). The number of lung metastatic nodules three weeks after inoculation of F10-MUC1-C8 cells was significantly lower in mice immunized with MUC1 plasmid DNA than in mice immunized with the vector DNA alone. Thus, the suppression of lung metastasis was antigen-specific. In vivo depletion of lymphocyte subpopulations by specific antibodies revealed that natural killer cells are the major effector cells responsible for the suppression of lung metastasis. CD4(+) cells and CD8(+) cells apparently played some roles too.
引用
收藏
页码:689 / 696
页数:8
相关论文
共 50 条
  • [21] Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with MUC1-C3d fusion protein
    Ohta, Rieko
    Imai, Masaki
    He, Chun
    Ross, Ted M.
    Tomlinson, Stephen
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 221 - 221
  • [22] Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells
    Gong, JL
    Chen, DS
    Kashiwaba, M
    Li, YQ
    Chen, L
    Takeuchi, H
    Qu, H
    Rowse, GJ
    Gendler, SJ
    Kufe, D
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) : 6279 - 6283
  • [23] Differential effector mechanisms induced by vaccination with MUC1 DNA in the rejection of colon carcinoma growth at orthotopic sites and metastases
    Sugiura, Daisuke
    Aida, Satoshi
    Denda-Nagai, Kaori
    Takeda, Kazuyoshi
    Kamata-Sakurai, Mika
    Yagita, Hideo
    Irimura, Tatsuro
    CANCER SCIENCE, 2008, 99 (12): : 2477 - 2484
  • [24] Unique effector mechanisms induced by vaccination with MUC1 DNA in the rejection of colon carcinoma growth at orthotopic sites and metastases
    Sugiura, Daisuke
    Aida, Satoshi
    Denda-Nagai, Kaori
    Kamata-Sakurai, Mika
    Takeda, Kazuyoshi
    Yagita, Hideo
    Irimura, Tatsuro
    CANCER RESEARCH, 2009, 69
  • [25] Immunotherapy with mannan-MUC1 and IL-12 in MUC1 transgenic mice
    Lees, CJ
    Apostolopoulos, V
    Acres, B
    Ramshaw, I
    Ramsay, A
    Ong, CS
    McKenzie, IFC
    VACCINE, 2000, 19 (2-3) : 158 - 162
  • [26] In vivo bioluminescence visualization of antitumor effects by human MUC1 vaccination
    Jeon, Yong Hyun
    Choi, Yun
    Kim, Hyun Joo
    Kang, Joo Hyun
    Kim, Chul Woo
    Jeong, Jae Min
    Lee, Dong Soo
    Chung, June-Key
    MOLECULAR IMAGING, 2007, 6 (05): : 297 - 303
  • [27] Intramuscular immunisation with MUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneic mouse tumour cells
    Graham, RA
    Burchell, JM
    Beverley, P
    TaylorPapadimitriou, J
    INTERNATIONAL JOURNAL OF CANCER, 1996, 65 (05) : 664 - 670
  • [28] The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer
    Curry, Jennifer M.
    Thompson, Kyle J.
    Rao, Shanti G.
    Besmer, Dahlia M.
    Murphy, Andrea M.
    Grdzelishvili, Valery Z.
    Ahrens, William A.
    McKillop, Iain H.
    Sindram, David
    Iannitti, David A.
    Martinie, John B.
    Mukherjee, Pinku
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (07) : 713 - 722
  • [29] Vaccination with allogeneic dendritic induces antitumor immunity in cells fused to carcinoma cells MUC1 transgenic mice
    Tanaka, Y
    Koido, S
    Chen, DS
    Gendler, SJ
    Kufe, D
    Gong, JL
    CLINICAL IMMUNOLOGY, 2001, 101 (02) : 192 - 200
  • [30] MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice
    Lakshminarayanan, Vani
    Supekar, Nitin T.
    Wei, Jie
    McCurry, Dustin B.
    Dueck, Amylou C.
    Kosiorek, Heidi E.
    Trivedi, Priyanka P.
    Bradley, Judy M.
    Madsen, Cathy S.
    Pathangey, Latha B.
    Hoelzinger, Dominique B.
    Wolfert, Margreet A.
    Boons, Geert-Jan
    Cohen, Peter A.
    Gendler, Sandra J.
    PLOS ONE, 2016, 11 (01):